Coppell Advisory Solutions’s iShares Biotechnology ETF IBB Stock Holding History

Coppell Advisory Solutions’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$493K	Buy	+60	New	+$10.3K	0.04%	291
2025 Q1	–	Sell	-59	Closed	-$7.77K	–	1026
2024 Q4	$7.77K	Hold	59	–	–	﹤0.01%	1202
2024 Q3	$8.55K	Buy	59 +15	+34%	+$2.17K	﹤0.01%	1130
2024 Q2	$6.07K	Buy	+44	New	+$5.87K	﹤0.01%	1155
2023 Q4	$14.7K	Buy	108 +84	+350%	+$10.2K	﹤0.01%	833
2023 Q3	$3.16K	Hold	24	–	–	﹤0.01%	795
2023 Q2	$3.04K	Buy	+24	New	+$3.12K	﹤0.01%	953
2023 Q1	–	Sell	-24	Closed	-$3.16K	–	615
2022 Q4	$3.16K	Buy	+24	New	+$3.1K	﹤0.01%	797

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Coppell Advisory Solutions's IBB Position: Q2 2026 in Review

Coppell Advisory Solutions opened a new position in iShares Biotechnology ETF (IBB) in Q2 2026: 60 shares worth $493K. The stake represents 0.04% of the portfolio and ranks #291 among its holdings. This is a return to the name: Coppell Advisory Solutions previously reported a position in IBB as recently as Q4 2024.

Coppell Advisory Solutions first reported a position in IBB in Q4 2022 and has held it in 8 quarters since. 956 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

Coppell Advisory Solutions held 60 shares of iShares Biotechnology ETF worth $493K as of Q2 2026.
iShares Biotechnology ETF was a new Coppell Advisory Solutions position in Q2 2026.
iShares Biotechnology ETF made up 0.04% of Coppell Advisory Solutions's portfolio in Q2 2026, its #291 holding.
Coppell Advisory Solutions first reported a position in iShares Biotechnology ETF in Q4 2022 and has held it in 8 quarters since.
956 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Coppell Advisory Solutions's 13F filing for Q2 2026, filed 14 Aug 2026.